Comparable virus inactivation by bovine or vegetable derived tween 80 during solvent/detergent treatment

Biologicals

Volumn 30, Issue 3, 2002, Pages 197-205

  Seitz, Holger ^a   Blümel, Johannes ^a   Schmidt, Ivo ^a   Willkommen, Hannelore ^a   Löwer, Johannes ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

Author keywords

Enveloped viruses; Inactivation; S D treatment; Tween 80

Indexed keywords

DETERGENT; POLYSORBATE 20; SOLVENT;

ARTICLE; BOVINE DIARRHEA VIRUS; CATTLE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PSEUDORABIES HERPETOVIRUS; SEMLIKI FOREST ALPHAVIRUS; TEMPERATURE; VEGETABLE; VESICULAR STOMATITIS VIRUS; VIRUS INACTIVATION; VIRUS TITRATION;

BOVINAE; SEMLIKI FOREST VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 0036771406     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1006/biol.2002.0328     Document Type: Article

References (15)

1. Horowitz B., Wiebe M.E., Lippin A., Stryker M.H. Inactivation of viruses in labile blood derivatives. I. Disruption of lipid-enveloped viruses by tri(n-butyl)phosphate detergent combinations. Transfusion. 25:1985;516-522.
2. Horowitz B., Wiebe M.E., Lippin A., Vandersande J., Stryker M.H. Inactivation of viruses in labile blood derivatives. II. Physical methods. Transfusion. 25:1985;523-527.
3. Dichtelmüller H., Rudnick D., Breuer B., Kotitischke R., Kloft M., Darling A., Watson E., Flehmig B., Lawson S., Frösner G. Improvement of virus safety of a S/D-treated factor VII concentrate by additional dry heat treatment at 100° C. Biologicals. 24:1996;125-130.
4. Eriksson B., Westman L., Jernberg M. Virus validation of plasma-derived products produced by Pharmacia, with particular reference to immunoglobulins (review paper). Blood Coagulation and Fibrinolysis. 5:1994;S37-S44.
5. Horowitz B., Bonomo R., Prince A.M., Chin S.N., Brotman B., Shulman R.W. Solvent/detergent treated plasma: A virus-inactivated substitute for fresh frozen plasma. Blood. 79:1992;826-831.
6. Uemura Y., Joy Yang Y.H., Heldebrant C.M., Takechi K., Yokoyama. Inactivation and elimination of viruses during preparation of human intravenous immunoglobulin. Vox. Sanguinis. 67:1994;1-9.
7. Alonso W.R., Trukawinski S., Savage M., Tenold R.A., Hammond D.J. Viral inactivation of intramuscular immune serum globulins. Biologicals. 28:2000;5-15.
8. Johnston A., MacGregor A., Borovec S., Hattarki M., Stuckly K., Anderson D., Goss N.H., Oates A., Uren E. Inactivation and clearance of viruses during the manufacture of high purity factor IX. Biologicals. 28:2000;129-136.
9. Roberts P. Resistance of vaccinina virus to inactivation by solvent/detergent treatment of blood products. Biologicals. 28:2000;29-32.
10. Biesert L. Virus validation studies of immunoglobulin preparations. Clin Exp Rheumatol. 14:1996;47-52.
11. Committee for Proprietary Medicinal Products, European Medicines Evaluation Agency.
12. Committee for Proprietary Medicinal Products, European Medicines Evaluation Agency.
13. Roberts P., Sims G. Use of vegetable-derived Tween 80 for virus inactivation by solvent/detergent treatment. Biologicals. 27:1999;263-264.
14. Klein H.G., Dodd R.Y., Dzik W.H., Luban N.L., Ness P.M., Pisciotto P., Schiff P.D., Snyder E.L. Current status of solvent/detergent-treated frozen plasma. Transfusion. 38:1998;102-107.
15. Edwards C.A., Piet M.P.J., Chin S., Horowitz B. Tri(n-butyl)phosphate/detergent treatment of licensed therapeutic and experimental blood derivatives. Vox Sang. 52:1987;53-59.